XORTX Prepares for Shareholders’ Vote on Key Resolutions

XORTX Therapeutics Inc (TSE:XRTX) has released an update.

XORTX Therapeutics Inc. is gearing up for its Annual General and Special Meeting on September 12, 2024, urging shareholders to vote on key proposals including electing directors and approving an amended Stock Option Plan. The company, which specializes in developing treatments for progressive kidney disease, has received a vote of confidence from the proxy advisory firm ISS recommending a ‘FOR’ vote on all resolutions. Shareholders are reminded to cast their votes by the deadline on September 10, 2024.

For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.